Processa Pharmaceuticals Enters Material Definitive Agreement
Ticker: PCSA · Form: 8-K · Filed: Jun 18, 2025 · CIK: 1533743
| Field | Detail |
|---|---|
| Company | Processa Pharmaceuticals, Inc. (PCSA) |
| Form Type | 8-K |
| Filed Date | Jun 18, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-definitive-agreement, corporate-update
TL;DR
Processa Pharma just signed a big deal, filing an 8-K. Details to follow.
AI Summary
On June 17, 2025, Processa Pharmaceuticals, Inc. entered into a material definitive agreement. The company, formerly known as Heatwurx, Inc. until October 28, 2011, is incorporated in Delaware and headquartered in Vero Beach, Florida. This filing is a current report under the Securities Exchange Act of 1934.
Why It Matters
This filing indicates a significant new agreement for Processa Pharmaceuticals, which could impact its business operations and future financial performance.
Risk Assessment
Risk Level: medium — Entering into material definitive agreements can carry inherent risks related to the terms, obligations, and potential outcomes of the agreement.
Key Numbers
- 001-39531 — Commission file number (SEC file number for Processa Pharmaceuticals, Inc.)
- 45-1539785 — I.R.S. Employer Identification Number (EIN for Processa Pharmaceuticals, Inc.)
Key Players & Entities
- Processa Pharmaceuticals, Inc. (company) — Registrant
- Heatwurx, Inc. (company) — Former company name
- June 17, 2025 (date) — Date of earliest event reported
- October 28, 2011 (date) — Date of name change
- Delaware (jurisdiction) — State of incorporation
- Vero Beach, FL (location) — Address of Principal Executive Offices
FAQ
What is the nature of the material definitive agreement entered into by Processa Pharmaceuticals, Inc. on June 17, 2025?
The filing states that Processa Pharmaceuticals, Inc. entered into a material definitive agreement on June 17, 2025, but the specific details of the agreement are not provided in this excerpt.
What was Processa Pharmaceuticals, Inc. previously known as?
Processa Pharmaceuticals, Inc. was formerly known as Heatwurx, Inc. until October 28, 2011.
In which state is Processa Pharmaceuticals, Inc. incorporated?
Processa Pharmaceuticals, Inc. is incorporated in Delaware.
What is the principal executive office address for Processa Pharmaceuticals, Inc.?
The principal executive offices are located at 601 21st Street, Suite 300, Vero Beach, FL 32960.
What is the Commission file number for Processa Pharmaceuticals, Inc.?
The Commission file number for Processa Pharmaceuticals, Inc. is 001-39531.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 18, 2025 regarding Processa Pharmaceuticals, Inc. (PCSA).